-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK: INTISMERAN PLUS KEYTRUDA REDUCED RECURRENCE/DEATH RISK BY 58%, REDUCED RISK OF DISTANT METASTASIS/DEATH BY HALF AT 6 MONTHS VS KEYTRUDA ALONE

Reuters·10/22/2026 18:22:57

Please log in to view news